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OBJECTIVE— Physical activity is associated with a reduced risk of developing diabetes and
with reduced mortality among diabetic patients. However, the effects of physical activity on the
number of years lived with and without diabetes are unclear. Our aim is to calculate the differ-
ences in life expectancy with and without type 2 diabetes associated with different levels of
physical activity.
RESEARCH DESIGN AND METHODS— Using data from the Framingham Heart
Study, we constructed multistate life tables starting at age 50 years for men and women. Tran-
sition rates by level of physical activity were derived for three transitions: nondiabetic to death,
nondiabetic to diabetes, and diabetes to death. We used hazard ratios associated with different
physical activity levels after adjustment for age, sex, and potential confounders.
RESULTS— For men and women with moderate physical activity, life expectancy without
diabetes at age 50 years was 2.3 (95% CI 1.2–3.4) years longer than for subjects in the low
physical activity group. For men and women with high physical activity, these differences were
4.2 (2.9–5.5) and 4.0 (2.8–5.1) years, respectively. Life expectancy with diabetes was 0.5 (1.0
to 0.0) and 0.6 (1.1 to0.1) years less for moderately active men and women compared with
their sedentary counterparts. For high activity, these differences were 0.1 (0.7 to 0.5) and 0.2
(0.8 to 0.3) years, respectively.
CONCLUSIONS— Moderately and highly active people have a longer total life expectancy
and live more years free of diabetes than their sedentary counterparts but do not spend more
years with diabetes.
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The prevalence of diabetes is increas-ing dramatically worldwide. In2000, 171 million people world-
wide were affected by diabetes. This num-
ber is expected to double by 2030, mainly
as a consequence of population aging and
urbanization (1). Type 2 diabetes is asso-
ciated with long-term complications and
a high burden of morbidity (2,3). Evi-
dence suggests an inverse association be-
tween physical activity and the risk of
developing diabetes (4–11). Physical ac-
tivity, through improving insulin sensitiv-
ity and glycemic control (12–14), has
been associated with reduced total mor-
tality among diabetic patients (15–20)
and the general population (21).
However, the effects of physical activ-
ity on the number of years lived with and
without diabetes are still unclear.
Whether, for example, higher levels of
physical activity would reduce the num-
ber of years lived with diabetes depends
on the balance of its effect on the risks of
developing diabetes and mortality. For in-
stance, it has been shown that nonsmok-
ers live longer with cardiovascular disease
than smokers because their total life
expectancy is 8 years longer (22). As
policy makers increasingly advocate
modification of risk factors with the aim
of decreasing population levels of disease
and disability (e.g., 23), it will be impor-
tant to analyze the extent to which this is
actually the case. The conundrum is that
modification of risk factors, such as
smoking and physical activity, will at the
same time decrease disease incidence and
increase survival to advanced age, which
is itself one of the strongest risk factors for
disease.
Our aim is to quantify the differences
in life expectancy without type 2 diabetes
(i.e., the average number of years lived
before the onset of diabetes or death) and
life expectancy with type 2 diabetes (i.e.,
the average number of years lived with
diabetes) associated with different levels
of physical activity.
RESEARCH DESIGN AND
METHODS— The Framingham
Heart Study cohort consisted of 5,209 re-
spondents (46% male) aged 28–62 years
residing in Framingham, Massachusetts,
between 1948 and 1951. The Framing-
ham cohort is primarily white and has
been followed extensively for 46 years for
the occurrence of cardiovascular disease
and death through surveillance of hospi-
tal admissions, death registries, and other
available medical sources. Examination of
participants, including an interview, a
physical examination, and laboratory
tests, has taken place biennially. Further
description of the Framingham Heart
Study can be found elsewhere (24).
To calculate transition rates by level
of physical activity, we pooled three non-
overlapping follow-up periods of 12
years. Each follow-up period started with
a measurement of physical activity. In the
present investigation, the follow-up peri-
ods started at the original exams 4 (1956–
1958), 11/12 (1969–1973), and 19/20
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(1985–1989). Using the pooling of re-
peated observations method (25), fol-
low-up information over three follow-up
periods was pooled, yielding a total of
9,773 observation intervals. The same
participant may thus be followed during
three periods until the event (first onset of
diabetes or death) occurs or the subject is
censored. Follow-up time and physical
activity status may differ in each interval.
After exclusion of subjects with diabetes
at exam 1 to exclude juvenile diabetes and
missing information on physical activity,
we studied 4,176 subjects at exam 4,
3,286 subjects at exam 11/12, and 1,660
subjects at exam 19/20, yielding a total of
9,122 follow-up observation intervals.
Diabetes assessment
Diabetes was considered present after a
random blood glucose level 200 mg/dl
or when the subject was treated with a
hypoglycemic agent (insulin and/or oral
hypoglycemic agent).
Assessment of physical activity
Participants were asked about their time
spent resting or engaged in light, moder-
ate, or heavy physical activity on an aver-
age day. Time spent at each activity in
hours per week was multiplied by its met-
abolic cost (based on the oxygen con-
sumption required for that activity) as
described before by Kannel et al. (26). A
weight of 1.0 was used for an activity with
oxygen consumption of 0.25 l/min, for
example sleep. Other weights were 1.1 for
being sedentary, 1.5 for light activity, 2.4
for moderate activity, and 5 for heavy ac-
tivity. The weight factor corresponds to a
metabolic equivalent task. These
weighted hours were added up to get a
total daily physical activity score. The
minimum physical activity score is 24,
which is equivalent to 24 h of rest/sleep.
Based on tertiles of the daily physical activ-
ity scores, we grouped the participants in
three levels: low (30), moderate (30–33),
and high (33) physical activity level.
Confounders
Potential confounders were measured at
the start of each follow-up period, except
for education. All analyses were adjusted
for age and sex. Confounders considered
were education (eighth grade or less/
higher than eighth grade), smoking
(never, ever, or current smoking), marital
status (single, married, widowed, or sep-
arated/divorced), diseases present at
baseline (any of the following: cardiovas-
cular disease, cancer, left ventricular hy-
pertrophy, arthritis, ankle edema, or any
pulmonary disease), total cholesterol,
family history of diabetes (diabetes in par-
ents and/or siblings), and the exam of
start follow-up (exam 4, 11/12, or 19/20).
The exam of start follow-up was included
to correct for a potential cohort and pe-
riod effect. Hypertension and BMI were
not considered as confounders but as in-
termediate factors, as physical activity
may cause individuals to have lower BMI
and blood pressure, which in turn re-
duces the risk of diabetes and mortality.
Adjustment for BMI and hypertension
may result in an underestimation of the
true beneficial effect of physical activity.
Hypertension was defined as systolic
blood pressure 140 mmHg or diastolic
blood pressure 90 mmHg (27). For
BMI, four categories were defined: BMI
18.5 kg/m2, 18.5  BMI  25 kg/m2,
25  BMI  30 kg/m2, and BMI 30
kg/m2. Because the information on alco-
hol consumption was not available for all
follow-up periods, alcohol was excluded
from the analyses. For the final analysis,
only participants who had information on
all confounders, BMI, and hypertension
were included (3,978, 3,067, and 1,561
subjects at exam rounds 4, 11/12, and 19/
20, respectively).
Data analysis
To calculate the life expectancy with and
without diabetes, we created a multistate
life table (MSLT) (28). This MSLT, which
combines information of people at differ-
ent ages and from different birth cohorts,
included three states: “free of diagnosed
diabetes,” “diabetes,” and “death.” The
possible transitions were from free of di-
agnosed diabetes to diabetes or to death
and from diabetes to death. No back flows
were allowed, and only the first entry into
a state was considered. Age 50 years was
chosen as the starting age to include the
effect of physical activity at adult ages,
while avoiding unstable rates due to lim-
ited number of events below age 50 years.
Another advantage is that at this age,
where the prevalence of type 2 diabetes is
still low, the outcomes of the MSLT for the
total and diabetes-free population are vir-
tually the same.
To obtain transition rates by levels of
physical activity, we first calculated the
overall sex- and age-specific transition
rates for each transition (29). Next, we
calculated hazard ratios of physical activ-
ity using Poisson regression. We analyzed
the effect of potential confounders on the
hazard ratios by first adjusting for age and
sex only and next by including the follow-
ing in addition: education, marital status,
smoking, baseline diseases, and exam of
start follow-up. Subsequently, adjust-
ments for BMI and hypertension were
added to the previous model to give in-
formation about the effect of these possi-
ble intermediates on the hazard ratios.
Additionally, adjusting for BMI did not
substantially change the hazard ratios.
The small effect of adjusting for BMI may
reflect a small risk of self-selection of
heavy subjects for lower physical activity
levels because physical activity includes
physical activity at work. We did not adjust
for total cholesterol (as continuous variable)
and family history of diabetes in the final
model, as these variables did not change the
hazard ratios of physical activity and had a
large number of missing values.
Finally, to calculate transition rates by
level of physical activity, we used the
overall transition rates, the prevalence of
the different levels of physical activity in
the population (stratified by 10-year age-
group, sex, and diabetes), and the hazard
ratios of physical activity adjusted for po-
tential confounding but not for interme-
diates (BMI and hypertension).
Separate MSLTs were created for each
level of physical activity for men and
women, incorporating each of the three
transitions. The MSLT started at age 50
years and was closed at age 100 years. The
measures available from the MSLT in-
clude life expectancy without diagnosed
diabetes (i.e., the average number of years
lived free of diabetes before the onset of
diabetes or death) and life expectancy
with diabetes (i.e., the average number of
years lived with diabetes) for populations
with either low, moderate, or high phys-
ical activity and free of diabetes at age 50
years.
All statistical analyses were done us-
ing STATA version 8.2 for Windows
(Stata, College Station, TX). We calcu-
lated CIs for all life expectancies and dif-
ferences in life expectancies using Monte
Carlo simulation (parametric bootstrap-
ping) (30). To calculate the CIs, we used
@RISK (Anonymous 2000; MathSoft)
10,000 runs.
RESULTS
Baseline characteristics
In the categories low and moderate phys-
ical activity, the proportion of women was
higher than in the category with high
physical activity (63 and 62%, respec-
Jonker and Associates
DIABETES CARE, VOLUME 29, NUMBER 1, JANUARY 2006 39
tively, compared with 46%) (Table 1).
Participants in the low physical activity
group tended to be older (mean age 62
years) compared with the participants
of the moderate and high activity
groups (mean age 58 and 59 years, respec-
tively); also, the level of baseline diseases
was higher among participants with low
physical activity. Blood pressure and total
cholesterol showed a tendency toward an
inverse relationship with physical activity
(Table 1).
Risk of diabetes and death
Higher levels of physical activity were as-
sociated with lower rates of incident
diabetes (corrected for age and sex) (on-
line appendix [available at http://care.
diabetesjournals.org]). After additional
correction for selected confounders, the
effect slightly increased and the hazard
ratio remained significant (Table 2).
The risks of mortality in subjects
without diagnosed diabetes (corrected for
age and sex) were inversely related to the
level of physical activity (Table 2). Cor-
recting for confounders slightly attenu-
ated the effect, but all hazard ratios
remained significant. The mortality rates
in subjects with diabetes were also lower
in active subjects than in sedentary sub-
jects. After adjusting for confounders, this
association was only significant for high
physical activity.
Total life expectancy and life
expectancy with and without
diabetes
Figure 1 shows survival curves, total and
free of diabetes, by level of physical activ-
ity. The area under these survival curves is
total life expectancy and life expectancy
without diabetes, respectively. The differ-
ence between the total and diabetes-free
life expectancy is life expectancy with di-
abetes. At age 50 years, total life expect-
ancy was 27.2 (men) and 33.8 (women)
years, of which 25.5 and 32.1 years, re-
spectively, were spent without diabetes
and 1.7 years (both sexes) with diabetes.
In contrast, life expectancy of 50-year-old
individuals with diabetes is 23.8 and 24.3
years for men and women, respectively.
Life expectancy of 50-year-old men in
the moderate and high activity groups
was 1.8 (95% CI 0.8–2.9) and 4.1 (2.8–
5.4) years longer, respectively, than of
men in the lowest activity group. For
women, these differences were similar:
1.7 (0.8–2.8) and 3.7 (2.6–4.9) years
(Table 3). This larger total life expectancy
was composed of more years lived with-
out diabetes and fewer years lived with
diabetes. Both moderately active men and
women lived 2.3 (1.2–3.4) more years
without diabetes than those in the lowest
activity group (Table 3). In the highest
activity group, men and women lived 4.2
(2.9–5.5) and 4.0 (2.8–5.1) years longer,
respectively, without diabetes than their
sedentary counterparts. Moderately ac-
tive men and women lived 0.5 (men:
95% CI 1.0 to 0.0, women: 1.1 to
0.1) years less with diabetes, compared
with those with low physical activity. For
high activity groups these differences for
men and women were 0.1 and 0.2 years,
Table 1—Baseline characteristics by physical activity level*
Level of physical activity (tertiles)
Low Moderate High
n 2,829 (31) 3,329 (36) 2,964 (32)
Physical activity score 28.1  1.2 31.4  1.0 38.0  5.4
Age (years) 61.6  13.1 57.6  12.3 59.1  11.8
Women 1,776  63 2,065  62 1,362  46
Marital status
Single 277 (10) 279 (8) 177 (6)
Married 1,923 (68) 2,517 (76) 2,410 (81)
Widowed 514 (18) 417 (13) 290 (10)
Divorced/separated 72 (3) 86 (3) 62 (2)
Education, eighth grade or less 696 (25) 843 (25) 738 (25)
Never smoker 1,112 (39) 1,222 (37) 868 (29)
Former smoker 662 (23) 750 (23) 864 (29)
Current smoker 1,055 (37) 1,357 (41) 1,232 (42)
Baseline diseases† 1,543 (55) 1,373 (41) 1,225 (41)
BMI (kg/m2) 26.2  4.6 25.9  4.1 26.1  3.9
Systolic blood pressure (mmHg) 140.2  24.2 137.2  22.6 136.2  20.9
Diastolic blood pressure (mmHg) 89.0  24.2 84.8  18.0 84.3  17.7
Total cholesterol (mg/100 ml) 239.0  46.7 234.4  43.3 230.6  41.6
Family history of diabetes‡ 479 (17) 560 (17) 508 (17)
Data are means SD or n (%). *After exclusion of subjects with diabetes at baseline and missing information
on physical activity. †Baseline diseases: cardiovascular disease, cancer, left ventricular hypertrophy, arthritis,
ankle edema, or pulmonary disease. ‡Family history of diabetes defined as diabetes diagnosed in parents
and/or siblings.
Table 2—Hazard ratios for the different transitions
Transition n Person-years Physical activity Hazard ratio (95% CI)* Hazard ratio (95% CI)†
Incident diabetes 329 70,115 Low 1.00 1.00
Moderate 0.63 (0.48–0.82) 0.62 (0.47–0.80)
High 0.63 (0.49–0.83) 0.60 (0.46–0.80)
No diagnosed diabetes to death 1,598 71,856 Low 1.00 1.00
Moderate 0.81 (0.72–0.91) 0.86 (0.76–0.96)
High 0.61 (0.54–0.69) 0.70 (0.61–0.79)
Diabetes to death 292 4,922 Low 1.00 1.00
Moderate 0.72 (0.55–0.95) 0.81 (0.61–1.07)
High 0.47 (0.35–0.64) 0.53 (0.39–0.72)
*Adjusted for age and sex. †Adjusted for age; sex; education; marital status; smoking; baseline diseases, such as cardiovascular disease, cancer, left ventricular
hypertrophy, arthritis, ankle edema, or pulmonary disease; and exam of start follow-up.
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respectively, but were no longer signifi-
cant (Table 3).
CONCLUSIONS— Moderately and
highly active people live longer and spend
more years without diabetes than subjects
with low physical activity levels. At age 50
years, life expectancy free of diabetes is
2.3 years longer for moderately active
men and women and at least 4 years
longer for highly active men and women.
The effect of physical activity on life ex-
pectancy without diabetes reflects both
the lower incidence of diabetes and the
lower mortality of nondiabetic individu-
Figure 1—A: Survival curves illustrating the probability of surviving with age by sex for different levels of physical activity (low, moderate, and
high). The area under the survival curve is the total life expectancy for populations with low, moderate, or high physical activity and free of diabetes
at age 50 years. B: Survival curves illustrating the probability of surviving free of diabetes with age by sex for different levels of physical activity (low,
moderate, and high). The area under the survival curve is life expectancy without diabetes for populations with low, moderate, or high physical
activity and free of diabetes at age 50 years.
Table 3—Life expectancy in years at age 50 years for three levels of physical activity*
Total life
expectancy*
Differences in
total life
expectancy†
Life expectancy
free of
diagnosed diabetes
Differences in
life expectancy
free of
diagnosed diabetes†
Life expectancy
with diabetes
Differences in
life expectancy
with diabetes†
Men
Low activity 25.3 (24.4–26.3) ref 23.3 (22.4–24.2) ref 2.0 (1.6–2.6) ref
Moderate activity 27.1 (26.0–28.0) 1.8 (0.8–2.9) 25.6 (24.4–26.8) 2.3 (1.2–3.4) 1.5 (1.1–2.1) 0.5 (1.0 to 0.0)
High activity 29.4 (28.3–30.5) 4.1 (2.8–5.4) 27.5 (26.3–28.7) 4.2 (2.9–5.5) 1.9 (1.5–2.5) 0.1 (0.7 to 0.5)
Women
Low activity 32.3 (31.5–33.1) ref 30.3 (29.4–31.2) ref 2.0 (1.7–2.5) ref
Moderate activity 34.0 (33.0–35.0) 1.7 (0.8–2.8) 32.6 (31.6–33.6) 2.3 (1.2–3.4) 1.5 (1.1–2.0) 0.6 (1.1 to 0.1)
High activity 36.0 (34.9–37.2) 3.7 (2.6–4.9) 34.2 (33.1–35.4) 4.0 (2.8–5.1) 1.8 (1.3–2.4) 0.2 (0.8 to 0.3)
Data are years (95% CI). *Life expectancy free of diagnosed diabetes is the average number of years lived free of diabetes prior to the onset of diabetes or death and
life expectancy with diabetes is the average number of years lived with diabetes. These life expectancies refer to a population alive and free of diabetes at age 50 years.
All life expectancies have been calculated with hazard ratios adjusted for age; sex; education; marital status; smoking; baseline diseases, such as cardiovascular disease,
cancer, left ventricular hypertrophy, arthritis, ankle edema, or pulmonary disease; and exam of start follow-up. †Differences are calculated using the low physical
activity group as reference: moderate vs. low and high vs. low. ref, reference.
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als associated with increasing physical ac-
tivity levels. Life expectancy with diabetes
is at least 0.5 and 0.1 years less for mod-
erate and highly active people, respec-
tively, compared with those with low
physical activity. This reflects two oppos-
ing effects: 1) lower incidence of diabetes
in the active group reducing the time
spent with diabetes and 2) lower mortality
in diabetic subjects, increasing the time
spent with diabetes. The net result is that
while moderate and highly active people
live longer, they do not spend more years
with diabetes.
The reported hazard ratios found in
our study fall well within the range of the
published measures of the effect of phys-
ical activity on incident diabetes (4–6,8,
9,31–33) and mortality of diabetic
subjects (15,16,19,20). However, com-
parison with prior studies is difficult be-
cause the measurement scales and
definitions of physical activity used differ.
Most studies published on the subject
(4,6,8,9,31,32) have found dose-
response relations between physical ac-
tivity and the incidence of diabetes. We
similarly found a dose-response relation
between physical activity and the mortal-
ity rates among nondiabetic and diabetic
subjects. However, similar to a few other
studies (5,33,34), we found that the de-
gree of protection against diabetes was
virtually the same in those with either vig-
orous or moderate physical activity levels.
Additional analyses (data not shown) sug-
gest that, in particular, the oldest subjects
are responsible for this lack of a clear
dose-response relation. Our data sug-
gested that the effect of physical activity
could be different in those aged 80
years. A possible explanation is that at this
age, the lower physical activity group still
at risk for diabetes is more selected due to
higher risks of diabetes and mortality ear-
lier in their life than those with higher
levels of physical activity. However, the
study was underpowered to detect any
true difference in effect, and it is unlikely
that such a difference would have affected
our conclusions. Similar to Gregg et al.
(20), the effect of moderate physical ac-
tivity on the transition of diabetes to death
did not reach statistical significance after
full adjustment. Additional analyses
showed that using a hazard ratio of 1.00
for this transition in the moderate active
group would only strengthen our results.
A strength of this study is the use of
data from a prospective, well-organized
study, with long-term follow-up. Another
advantage is that the glucose levels as well
as other risk factors are measured at reg-
ular, biannual intervals. In our study, di-
agnosis of diabetes was based on glucose
tests or the use of hypoglycaemic agents
instead of self-report. In studies based on
self-reported diabetes, many subjects
with diabetes remain undiagnosed. In this
study, there could be underdiagnosis only
if subjects were not present at one or more
exams (or had a false-negative test). As
most subjects only missed one or a few sub-
sequent exams, it becomes more a matter of
delayed diagnosis than underdiagnosis.
Some limitations should be men-
tioned. The present study is an observa-
tional study and not a randomized trial.
Consequently, bias may occur if diseases
at baseline are responsible for inactivity
(reverse causation) and if other factors
confound the association between physi-
cal activity and the transition rates. There
are two approaches to avoid reverse cau-
sation: exclusion of subjects with known
diseases at baseline or adjustment for
baseline diseases in the analysis. We used
the second option, since we considered
that by excluding subjects with diseases at
baseline, there would be a selection of
healthy people, and therefore the results
would not be applicable to the whole
population.
Residual confounding cannot entirely
be ruled out, but as we examined the po-
tential effect of a large set of confounders
(age, sex, education, presence of diseases,
marital status, smoking, exam of start fol-
low-up, cholesterol, and family history of
diabetes) and included those that affected
the association between physical activity
and the transitions, we do not expect that
this would have biased our results.
Another limitation of our study is that
in the Framingham Heart Study, physical
activity levels were evaluated by self-
report, which may introduce misclassifi-
cation of exposure. However, this
misclassification is likely to be nondiffer-
ential, which can only attenuate our re-
sults and fade a stronger association. We
maximized the power of our study by us-
ing 12 years of follow-up. As a long period
of follow-up reduces the effect of selec-
tion, but increases the risk of misclassifi-
cation of exposure, the optimal follow-up
time is unknown. Since it has been re-
ported that levels and effects of physical
activity change with time (35), we evalu-
ated the effect of length of follow-up on
the relation between physical activity and
the transitions. These sensitivity analyses
showed that with a follow-up period of 8
or 10 years instead of 12 years, our main
conclusions did not change (data not
shown).
The added value of this study is the
combination of the observed effects of
physical activity on incidence of diabetes
and mortality in a large prospective study
and the translation into the population
health measures (life expectancy with and
without diabetes). This study shows that
physically inactive people have shorter
lives, and, moreover, they live fewer years
without diabetes and more or an equiva-
lent number of years with diabetes com-
pared with people with higher levels of
physical activity. These results underline
the public health importance of increas-
ing physical activity levels in the popu-
lation. Moreover, as Reunanen et al. (2)
found that total costs of medications for
people with diabetes were 3.5 times
greater than those for nondiabetic con-
trol subjects, our findings are also im-
portant for the health care sector. When
people live longer, but do not spend
more years with diabetes, they do not
put an extra demand on diabetes-
related health care.
As far as the associations reflect causal
relationships, our study suggests that if
sedentary people could be stimulated to
be at least moderately active, they could
extend their lives and increase their life-
time spent without diabetes without
spending more years with diabetes.
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